Holding(s) in Company

Summary by AI BETAClose X

Renalytix PLC announced that Harwood Capital LLP crossed a threshold due to an increase in the company's total issued share capital, following the recent admission of ordinary shares and a $4 million balance sheet improvement with bond conversion. The resulting total voting rights attached to shares for Harwood Capital LLP is now 3.903%, representing 17,061,345 voting rights. This is a decrease from the previously notified position of 4.411130%. The change in percentage is attributed to the increase in the company's total issued share capital rather than any disposal or acquisition of shares by Harwood Capital LLP.

Disclaimer*

UK 100

Latest directors dealings